Our present study found that, although the renal fibrosis is significantly different between SHRs and the UTMD‐targeted GRK4 siRNA–treated SHRs, the renal function, determined by BUN and creatinine, has no difference between two groups. The gene discussed is GRK4; the disease is renal fibrosis.